Medical News

Renal Clinical Outcomes of TAF Vs TDF-Based HIV Regimens

Tenofovir alafenamide (TAF)-containing regimens have demonstrated high efficacy and favorable changes in renal biomarkers including creatinine...

22 Jul, 2019

 
Email this page
D/C/F/TAF Demonstrates High Genetic Barrier, Efficacy and Safety in Treatment experienced, Virologically-suppressed HIV-1 Patients

EMERALD is a phase 3, randomized, active-controlled, open-label, noninferiority study that assessed the efficacy of darunavir with cobicistat,...

19 Jul, 2019

 
Email this page
Switch to Dolutegravir plus Boosted-Darunavir Safe and Effective in Highly Treatment-experienced HIV Patients

In highly treatment-experienced patients harboring multidrug-resistant HIV virus, the combination of high genetic barrier drugs such as dolutegravir...

15 Jul, 2019

 
Email this page
Switch to Once-daily DOR/3TC/TDF, A Well-tolerated Option for Maintaining Viral Suppression in HIV-1 Patients

Doravirine (DOR) is a novel, nonnucleoside reverse transcriptase inhibitor with demonstrated efficacy in treatment-naive adults with HIV-1. A recent...

15 Jul, 2019

 
Email this page

Key Trials

TAF Based Regimen Superior to TDF–based Regimen in Efficacy and Renal and Bone Safety for Initial HIV-1 Treatment

This was a 144-week analysis comparing the efficacy and safety of TAF vs TDF, each co-formulated with elvitegravir, cobicistat, and emtricitabine (e...

Safety and Efficacy of E/C/F/TAF vs E/C/F/TDF in Treatment Naïve HIV Patients

This trial compares the safety and efficacy of TAF vs TDF co-formulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of...

REALITY: Enhanced Antimicrobial Prophylaxis + ART Improves Survival in Advanced HIV Patients

This study compared the enhanced and standard antimicrobial prophylaxis treatment in patients with advanced HIV disease.

Pre-exposure Chemoprophylaxis with Oral FTC–TDF Prevents HIV Acquisition in Men Who have Sex with Men

Pre-exposure Prophylaxis Initiative (iPrEx) trial was a randomized, double-blind, placebo controlled trial aimed to evaluate the safety and efficacy...

Our Publications

Antiretroviral-based Prevention Strategies in HIV

Today, antiretroviral therapy (ART) is not only known to keep HIV-infected patients alive but is also being harnessed as a strategy to prevent...

Antiretroviral Therapy – Current Recommendations

Advances in the treatment of HIV infection has resulted in a dramatic shift, from a deadly infectious disease to a chronic manageable condition....

Datasheet: Lopinavir and Ritonavir (40mg/10mg) Oral Pellets

Lopinavir and Ritonavir (40 mg / 10 mg) Oral Pellets is a Novel oral pellet formulation for paediatric use. This datasheet contains the entire...

Fast Facts: Lopinavir and Ritonavir (40 mg/10 mg) Oral Pellets

Lopinavir and Ritonavir (40 mg / 10 mg) Oral Pellets is a Novel oral pellet formulation for paediatric use. This booklet contains information about...

Patient Education

Live Healthier, Live Longer

This publication features commonly asked questions by HIV patients regarding HIV therapy, drug side-effects, Do’s and Don’ts while on HIV treatment....

Living with Hope

This publication features common questions which arise in HIV patients mind regarding HIV, diagnosis, transmission, treatment and drug side effects. ...

Slide Library

HIV - HCV Coinfection

This slide set covers the epidemiology, disease progression and management of HIV-HCV coinfection in the era of directly acting antivirals available...

 
Email this page
HIV - Pre-exposure Prophylaxis (PrEP): Guidance on PrEP Use

PrEP is the use of an antiretroviral medication by HIV-negative individuals to prevent them from acquiring HIV. These slides give an overview on the...

 
Email this page
HIV- Post-exposure Prophylaxis (PEP)

Post-exposure prophylaxis (PEP) is the method of preventing exposures of HIV to blood and body fluids and it is considered to be the most important...

 
Email this page
Isoniazid Preventive Therapy in HIV Infection

HIV is the strongest risk factor for developing tuberculosis (TB) disease in those with latent or new Mycobacterium tuberculosis infection....

 
Email this page

Poll

Which is your preferred 3rd drug in a first-line regimen?
Efavirenz 600
75% (3 votes)
Efavirenz 400
0% (0 votes)
Dolutegravir
25% (1 vote)
Total votes: 4